{"id":9415,"date":"2020-10-05T12:13:01","date_gmt":"2020-10-05T16:13:01","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=9415"},"modified":"2020-10-05T12:13:01","modified_gmt":"2020-10-05T16:13:01","slug":"silver-law-group-investigates-aquestive-therapeutics-inc-aqst","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/","title":{"rendered":"Silver Law Group Investigates Aquestive Therapeutics, Inc. (AQST)"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-9416 size-full\" src=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/10\/Aquestive-Therapeutics-Inc.-AQST.jpg\" alt=\"Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws. If you have losses from investing in Aquestive Therapeutics, Inc. (AQST) stock, contact Silver Law Group for consultation at no cost at (800) 975-4345 or by email at ssilver@silverlaw.com. Aquestive Therapeutics, Inc. (AQST) Drug Libervant Aquestive Therapeutics, Inc. (AQST) is a specialty pharmaceutical company based out of New Jersey that \u201cfocuses on identifying, developing, and commercializing various products to address unmet medical needs.\u201d On September 25, 2020, Aquestive said that it had received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) for its New Drug Application for Libervant Buccal Film. Libervant is a drug being developed to manage seizure clusters.\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/10\/Aquestive-Therapeutics-Inc.-AQST.jpg 300w, https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/10\/Aquestive-Therapeutics-Inc.-AQST-180x120.jpg 180w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws.<\/p>\n<p><strong>If you have losses from investing in <\/strong><strong>Aquestive Therapeutics, Inc. (AQST) stock, contact Silver Law Group for consultation at no cost at (800) 975-4345 or by email at <\/strong><a href=\"mailto:ssilver@silverlaw.com\" target=\"_blank\"><strong>ssilver@silverlaw.com<\/strong><\/a><strong>. <\/strong> <a href=\"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/#more-9415\" class=\"more-link\">Continue reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws. If you have losses from investing in Aquestive Therapeutics, Inc. (AQST) stock, contact Silver Law Group for consultation at no cost at (800) 975-4345 or by email at ssilver@silverlaw.com. Continue reading \u203a<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602,1646],"tags":[],"class_list":["post-9415","post","type-post","status-publish","format-standard","hentry","category-class-action","category-securities-fraud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Silver Law Group Investigates Aquestive Therapeutics, Inc. (AQST) &#8212;<\/title>\n<meta name=\"description\" content=\"Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Silver Law Group Investigates Aquestive Therapeutics, Inc. (AQST) &#8212;\" \/>\n<meta name=\"twitter:description\" content=\"Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/10\/Aquestive-Therapeutics-Inc.-AQST.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Silver Law Group Investigates Aquestive Therapeutics, Inc. (AQST) &#8212;","description":"Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/","twitter_card":"summary_large_image","twitter_title":"Silver Law Group Investigates Aquestive Therapeutics, Inc. (AQST) &#8212;","twitter_description":"Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws.","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/10\/Aquestive-Therapeutics-Inc.-AQST.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/","url":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/","name":"Silver Law Group Investigates Aquestive Therapeutics, Inc. (AQST) &#8212;","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/10\/Aquestive-Therapeutics-Inc.-AQST.jpg","datePublished":"2020-10-05T16:13:01+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws.","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/10\/Aquestive-Therapeutics-Inc.-AQST.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/10\/Aquestive-Therapeutics-Inc.-AQST.jpg","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/silver-law-group-investigates-aquestive-therapeutics-inc-aqst\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Silver Law Group Investigates Aquestive Therapeutics, Inc. (AQST)"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=9415"}],"version-history":[{"count":2,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9415\/revisions"}],"predecessor-version":[{"id":9418,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9415\/revisions\/9418"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=9415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=9415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=9415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}